IA
IRON icon

IFP Advisors’s Disc Medicine IRON Stock Holding History

IFP Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73 Sell
1
-2
-67% -$137 ﹤0.01% 4994
2026
Q1 		$192 Hold
3
– – ﹤0.01% 4625
2025
Q4 		$238 Hold
3
– – ﹤0.01% 4446
2025
Q3 		$198 Buy
+3
New +$178 ﹤0.01% 4402
2025
Q2 		– Sell
-1
Closed -$47 – 4166
2025
Q1 		$50 Hold
1
– – ﹤0.01% 4022
2024
Q4 		$63 Buy
+1
New +$58 ﹤0.01% 4185

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IFP Advisors's IRON Position: Q2 2026 in Review

IFP Advisors reduced its Disc Medicine (IRON) stake by 67% in Q2 2026, selling an estimated $137 and leaving 1 share worth $73. The position accounts for ﹤0.01% of the portfolio, ranked #4994.

IFP Advisors first reported a position in IRON in Q4 2024 and has held it in 6 quarters since. The position peaked at $238 in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • IFP Advisors held 1 share of Disc Medicine worth $73 as of Q2 2026.
  • IFP Advisors sold 2 Disc Medicine shares in Q2 2026, an estimated $137.
  • Disc Medicine made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4994 holding.
  • IFP Advisors first reported a position in Disc Medicine in Q4 2024 and has held it in 6 quarters since.
  • IFP Advisors's Disc Medicine position peaked at $238 in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.